Company Filing History:
Years Active: 1991
Title: The Innovations of Fritz Demmer: Pioneering Stabilized Erythropoietin Preparations
Introduction
Fritz Demmer, an accomplished inventor based in Hirschberg-Leutershausen, Germany, has made significant contributions to the field of biotechnology. His pioneering work focuses on the stabilization of erythropoietin preparations, which has notable implications for medical treatment and research.
Latest Patents
Demmer holds a patent for "Stabilized Erythropoietin Preparations." This innovative invention details a compatible and storage-stable human protein preparation, crucial for injectable applications. The preparation comprises a human protein mixed with a physiologically compatible buffer and may include complex formers, isotonia-adjusting agents, and other materials suited for injection purposes. Specifically, it contains between 5 to 50 g/liter of urea, 1 to 50 g/liter of amino acids, and 0.05 to 5 g/liter of a non-ionic wetting agent. Additionally, the patent outlines the process for producing this preparation, highlighting Demmer's technical expertise and innovative thinking.
Career Highlights
Fritz Demmer works with Boehringer Mannheim GmbH, a leading company in the field of biotechnology and pharmaceuticals. His role has allowed him to engage deeply with groundbreaking projects, particularly in the realm of protein preparations and their applications in therapeutic settings.
Collaborations
Throughout his career, Demmer has collaborated with esteemed colleagues, including Heinrich Woog and Werner Gruber. These professional partnerships have fostered an environment of innovation and have contributed to the successful development of significant projects in their field.
Conclusion
Fritz Demmer's contributions to the field of biotechnology, especially through his patent for stabilized erythropoietin preparations, highlight his role as a valuable inventor. His work not only reflects his expertise but also enhances the possibilities for medical treatments involving human proteins. Through collaborations with his peers at Boehringer Mannheim GmbH, Demmer continues to influence the landscape of healthcare innovation.